Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

Journal of Experimental Medicine

Volumn 203, Issue 5, 2006, Pages 1249-1258

  Wille Reece, Ulrike ^a   Flynn, Barbara J ^a   Loré, Karin ^a   Koup, Richard A ^a   Miles, Aaron P ^a   Saul, Allan ^a   Kedl, Ross M ^b,d   Mattapallil, Joseph J ^a   Weiss, Walter R ^c   Roederer, Mario ^a   Seder, Robert A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b 3M COMPANY   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOMODULATING AGENT; MONTANIDE ISA 51; PROTEIN INHIBITOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 7 AGONIST; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 8 AGONIST; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CPG ISLANDS; CYTOKINES; GENE PRODUCTS, GAG; IMMUNIZATION; IMMUNOLOGIC MEMORY; MACACA MULATTA; MANNITOL; OLEIC ACIDS; OLIGODEOXYRIBONUCLEOTIDES; TH1 CELLS; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8; VIRAL VACCINES;

EID: 33646697743     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20052433     Document Type: Article

References (27)

1. Seder, R.A., and A.V. Hill. 2000. Vaccines against intracellular infections requiring cellular immunity. Nature. 406:793-798.
2. Baba, T.W., Y.S. Jeong, D. Pennick, R. Bronson, M.F. Greene, and R.M. Ruprecht. 1995. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science. 267:1820-1825.
3. Shiver, J.W., T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, R.K. Evans, Z.Q. Zhang, A.J. Simon, W.L. Trigona, S.A. Dubey, et al. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature. 415:331-335.
4. Seaman, M.S., L. Xu, K. Beaudry, K.L. Martin, M.H. Beddall, A. Miura, A. Sambor, B.K. Chakrabarti, Y. Huang, R. Bailer, et al. 2005. Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys. J. Virol. 79:2956-2963.
5. Donnelly, J.J., B. Wahren, and M.A. Liu. 2005. DNA vaccines: progress and challenges. J. Immunol. 175:633-639.
6. Casimiro, D.R., L. Chen, T.M. Fu, R.K. Evans, M.J. Caulfield, M.E. Davies, A. Tang, M. Chen, L. Huang, V. Harris, et al. 2003. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77:6305-6313.
7. Santra, S., M.S. Seaman, L. Xu, D.H. Barouch, C.I. Lord, M.A. Lifton, D.A. Gorgone, K.R. Beaudry, K. Svehla, B. Welcher, et al. 2005. Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates. J. Virol. 79:6516-6522.
8. + T cell responses in nonhuman primates. Proc. Natl. Acad. Sci. USA. 102:15190-15194.
9. Aucouturier, J., L. Dupuis, S. Deville, S. Ascarateil, and V. Ganne. 2002. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev. Vaccines. 1:111-118.
10. Pitcher, C.J., S.I. Hagen, J.M. Walker, R. Lum, B.L. Mitchell, V.C. Maino, M.K. Axthelm, and L.J. Picker. 2002. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168:29-43.
11. Wherry, E.J., V. Teichgraber, T.C. Becker, D. Masopust, S.M. Kaech, R. Antia, U.H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-234.
12. + central memory T cells in protection from simian AIDS. J. Immunol. 175:3502-3507.
13. Ahlers, J.D., N. Dunlop, C.D. Pendleton, M. Newman, P.L. Nara, and J.A. Berzofsky. 1996. Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization. AIDS Res. Hum. Retroviruses. 12:259-272.
14. Kumar, S., T.R. Jones, M.S. Oakley, H. Zheng, S.P. Kuppusamy, A. Taye, A.M. Krieg, A.W. Stowers, D.C. Kaslow, and S.L. Hoffman. 2004. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine. Infect. Immun. 72:949-957.
15. + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J. Clin. Invest. 115:739-746.
16. Wu, C.Y., J.R. Kirman, M.J. Rotte, D.F. Davey, S.P. Perfetto, E.G. Rhee, B.L. Freidag, B.J. Hill, D.C. Douek, and R.A. Seder. 2002. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3:852-858.
17. + T cells after acute infection. Nat. Immunol. 5:927-933.
18. Sun, J.C., and M.J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 300:339-342.
19. Shedlock, D.J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 300:337-339.
20. Zimmerli, S.C., A. Harari, C. Cellerai, F. Vallelian, P.A. Bart, and G. Pantaleo. 2005. HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl. Acad. Sci. USA. 102:7239-7244.
21. + T cells. J. Exp. Med. 200:701-712.
22. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068.
23. + T cells endowed with proliferative capacity. J. Exp. Med. 198:1909-1922.
24. Harari, A., S. Petitpierre, F. Vallelian, and G. Pantaleo. 2004. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood. 103:966-972.
25. Miles, A.P., H.A. McClellan, K.M. Rausch, D. Zhu, M.D. Whitmore, S. Singh, L.B. Martin, Y. Wu, B.K. Giersing, A.W. Stowers, et al. 2005. Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations. Vaccine. 23:2530-2539.
26. Gorden, K.B., K.S. Gorski, S.J. Gibson, R.M. Kedl, W.C. Kieper, X. Qiu, M.A. Tomai, S.S. Alkan, and J.P. Vasilakos. 2005. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR 8. J. Immunol. 174:1259-1268.
27. + T cells. Blood. In press.